Evercore reports Q1 earnings April 29 with positioning signals cooling after a sharp rally. The stock surged 24% over the past month but gave back 5% this week, closing at $344.30. Short interest remains negligible at 1.6% of float, down 18% over 30 days. Borrow costs have eased to 0.32% from 0.41% a month ago. Options positioning has flipped notably more bullish than usual — the put/call ratio dropped to 0.54, well below its 20-day mean of 1.01 and running 1.6 standard deviations below average. That's the most call-heavy setup in the past year. The move suggests traders are leaning into upside but the sharp stock pullback into the print raises the question of whether the rally ran too far too fast.
Analyst activity has turned cautious even as targets remain elevated. Goldman Sachs raised its price target from $335 to $374 on April 14, maintaining a Buy rating, but had previously cut the same target from $447 to $383 in March. Morgan Stanley lifted its Equal-Weight target to $384 from $381 earlier this month, but the modest tweak signals selectivity rather than conviction. UBS chopped its Neutral target from $383 to $313 in March, the sharpest trim in recent months. The consensus target of $367 sits just 7% above the current price, a compressed spread after the stock's recent run. Bulls point to advisory revenue strength — Q4 advisory fees hit $698 million, up 23% year-over-year and 19% ahead of estimates. M&A activity is expected to strengthen into late 2025 and 2026, supporting momentum. Bears focus on the compensation ratio, which fell to 65.4% in Q2, the only decline among coverage peers, and is projected to compress further. That signals rising operational pressure in a competitive environment.
Institutional holders have been adding modestly. BlackRock raised its stake by 46,000 shares to 3.5 million as of March 31. Fidelity added over 400,000 shares in the quarter, now holding 1.2 million. Insiders have been net sellers over the past 90 days, offloading $18.4 million worth of stock. Chairman and CEO John Weinberg sold $4.6 million on February 4, the same day co-founder Roger Altman unloaded $4.7 million. One director bought $581,000 worth of shares at $290 in early March, the only notable insider purchase. The stock rose 3.7% the day after the prior earnings print in early February, then added another 2% over the following five days. Peers have underperformed this week — Carlyle Group fell 8.3%, Stifel Financial dropped 6.2%, and PJT Partners shed 4.3%, all moving in line with or worse than Evercore's 5% decline.
The print will test whether advisory momentum can justify the recent valuation stretch and whether the firm can manage compensation headwinds as the Street models lower ratios ahead.
See the live data behind this article on ORTEX.
Open EVR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
